Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies

Conclusions: Patients with A genotype have a lower risk to develop G3 type I endometrial cancer. ABO blood group might represent a useful, easy access and cheap biomarker for patients' selection and for management personalization of endometrial cancer patients.

Source: Journal of Cancer - September 12, 2017 Category: Cancer & Oncology Authors: Vincenzo Dario Mandato, Federica Torricelli, Valentina Mastrofilippo, Gino Ciarlini, Debora Pirillo, Enrico Farnetti, Loretta Fornaciari, Bruno Casali, Maria Carolina Gelli, Martino Abrate, Lorenzo Aguzzoli, Giovanni Battista La Sala, Davide Nicoli Tags: Research Paper Source Type: research